Top compounds associated with response to TDRD10


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0008 1
mRNA TAK-715 GDSC1000 pan-cancer AAC 0.00075 1
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC 0.00072 1
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.00085 1
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.00065 1
mRNA AC220 GDSC1000 pan-cancer AAC -0.00071 1
mRNA TAE684 CCLE pan-cancer AAC 0.00086 1
mRNA etoposide GDSC1000 pan-cancer AAC 0.00056 1
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.00028 1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.00021 1
Download CSV